Back to Search Start Over

circKRT7-miR-29a-3p-COL1A1 Axis Promotes Ovarian Cancer Cell Progression.

Authors :
An, Qiang
Liu, Ting
Wang, Ming-yang
Yang, Yu-jia
Zhang, Zhen-dong
Lin, Zhen-jiang
Yang, Bing
Source :
OncoTargets & Therapy. Sep2020, Vol. 13, p8963-8976. 14p.
Publication Year :
2020

Abstract

Background: Circular RNA (circRNA) has emerged as an important regulator in the progression of human diseases. However, the role of circRNAs in ovarian cancer remains largely unknown. Materials and Methods: DNA sequencing and PCR were used to identify the existence and expression of circKRT7. The targeting relationship between circKRT7/miR-29a-3p and miR-29a-3p/COL1A1 was verified by fluorescence reporter assay. In vitro, colony formation, transwell and wound healing assay were used to detect the effects of circKRT7 and miR-29a-3p on the proliferation, migration and invasion ability of ovarian cancer cells. In vivo, xenograft tumor model was performed to validate the role of circKRT7 and miR-29a-3p in tumor growth. Results: We found that circKRT7 can promote the proliferation and metastasis of ovarian cancer cells by absorbing miR-29a-3p, which leads to the up-regulation of COL1A1. In vitro, knock-down of circKRT7 can inhibit the migration and invasion of ovarian cancer cells. This effect of circKRT7 is achieved by adsorbing miR-29a-3p and subsequently COL1A1 release. In vivo experiments, the reduction of circKRT7 expression can also slow tumor growth, and this inhibition was partly counteracted after miR-29a-3p repression. Conclusion: Overall, circKRT7 promotes EMT-related cell progression by absorbing miR-29a-3p in ovarian cancer. This suggests the crucial role of circular RNA in the malignant evolution in cancer. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11786930
Volume :
13
Database :
Academic Search Index
Journal :
OncoTargets & Therapy
Publication Type :
Academic Journal
Accession number :
146224957
Full Text :
https://doi.org/10.2147/OTT.S259033